PROGRAM OUTLINE What's included with the monthly price
*Correspondence: Isabelle Boileau [email protected] Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
Impact of Increased Residual Gastric Content on Clinical Consequences By increasing the risk of RGC, the use of GLP-1 RAs can have negative clinical consequences on patient outcomes
These studies will let us know more about how safe it is and how well it works when we compare it to other drugs
Are GLP-1 drugs genuinely transformative, or are we still in the hype phase
Holst JJ, Deacon CF, Vilsbll T, Krarup T, Madsbad S